Preparation method and application of paclitaxel albumin nanoparticles

A technology of albumin nanoparticles and paclitaxel, which is applied in the field of biomedical preparations, can solve the problems of consumption of yew trees, limited extraction of paclitaxel, low solubility of paclitaxel, etc., and achieves improved drug solubility, reduced toxicity or immune response, organic Reagent volume without residue effect

Inactive Publication Date: 2018-09-14
LIAONING UNIVERSITY
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The semi-synthetic method can maximize the utilization of plant resources, but it is not fundamentally different from the method of directly extracting paclitaxel. It needs to consume a large amount of yew trees, and still cannot fundamentally solve the problem

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and application of paclitaxel albumin nanoparticles
  • Preparation method and application of paclitaxel albumin nanoparticles
  • Preparation method and application of paclitaxel albumin nanoparticles

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0034] A preparation method of paclitaxel albumin nanoparticles includes the following steps:

[0035] 1) Weigh 50 mg of paclitaxel bulk drug, dissolve it in 1 mL of organic solvent, and sonicate for 30 minutes to obtain an oil phase. The organic solvent is dichloromethane, or acetone, or a mixture of dichloromethane and acetone (v:v=1:1).

[0036] 2) Weigh bovine serum albumin and dissolve it in water, stir and heat to fully dissolve it to obtain a bovine serum albumin aqueous solution with a mass volume percentage of 5% (m / v), and add 1mol / L hydrochloric acid to adjust the albumin aqueous solution. When the pH reaches 6.0, 1% of the total volume of the bovine serum albumin aqueous solution is added with an organic solvent to pre-saturate to obtain an aqueous phase. The organic solvent is dichloromethane, or acetone, or a mixture of dichloromethane and acetone (v:v=1:1).

[0037] 3) Under the action of high-speed shear (rotational speed 10000r), the oil phase is added dropwise to ...

Example Embodiment

[0039] Example 1

[0040] (1) Design of orthogonal experiment

[0041] Through experiments, it can be known that the type of organic solvent (A), the volume ratio of the oil phase to the water phase (B), and the number of homogenization (C) are the key factors influencing the particle size of the nanoparticles.

[0042] Type A of organic solvent: 1. Dichloromethane; 2. Acetone; 3. Dichloromethane-acetone (v:v=1:1);

[0043] The volume ratio of oil phase to water phase B: 1, 1:4; 2, 1:7; 3, 1:10;

[0044] The number of homogenization C: 1, 5 times; 2, 10 times; 3, 15 times, the experimental design is shown in Table 1:

[0045] Table 1 Orthogonal test design table

[0046]

[0047]

[0048] Table 2 Orthogonal test results

[0049]

[0050] Orthogonal design analysis table is shown in Table 2, in the table K 1 , K 2 , K 3 It is the average value of the experimental results (particle size) under the three levels of the corresponding factors, and the R value is the extreme difference of each fa...

Example Embodiment

[0062] Example 2

[0063] (1) A method for preparing paclitaxel albumin nanoparticles, including the following steps:

[0064] 1) Weigh 50 mg of paclitaxel bulk drug, dissolve it in 1 mL of acetone, and sonicate for 30 minutes to obtain an oil phase.

[0065] 2) Weigh bovine serum albumin and dissolve it in water, stir and heat to fully dissolve it to obtain an aqueous solution of bovine serum albumin with a mass volume percentage of 5% (m / v), and add 1mol / L hydrochloric acid to adjust the albumin aqueous solution. PH to 6.0, add 1% acetone of the total volume of the bovine serum albumin aqueous solution.

[0066] 3) Under the action of high-speed shear (rotating speed 10000r), the oil phase is added dropwise to the water phase to make an oil-in-water emulsion. According to the volume ratio, oil phase: water phase=1:10.

[0067] 4) Transfer the oil-in-water emulsion to a high-pressure micro-jet nano-disperser for high-pressure homogenization, the homogenization pressure is 1000 bar, a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Wavelengthaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention relates to a preparation method and application of paclitaxel albumin nanoparticles and belongs to the field of medicinal preparations. The preparation method includes: weighing paclitaxel active pharmaceutical ingredient, and dissolving in a proper amount of organic solvent to obtain an oil phase; weighing albumin, dissolving in water, stirring, heating to enable the albumin to be fully dissolved to obtain an albumin water solution, adjusting pH of the albumin water solution to 6.0, and adding the organic solvent to obtain an aqueous phase; under action of high-speed shearing, dropwise adding the oil phase into the aqueous phase to obtain an oil-in-water emulsion; transferring the oil-in-water emulsion into a high-pressure microjet nano dispersing instrument for high-pressure homogenizing, and removing the organic solvent from a system after homogenizing is completed through rotary evaporation to obtain a water solution of the paclitaxel albumin nanoparticles. Particle size of the paclitaxel albumin nanoparticles can be controlled by changing proportion of the oil phase and is 100-200nm. The preparation method is simple, controllable and suitable for industrial production.

Description

technical field [0001] The invention belongs to the field of biomedical preparations, in particular to the preparation and application of paclitaxel albumin nanoparticles. Background technique [0002] Paclitaxel is a natural secondary metabolite isolated and purified from the bark of the gymnosperm Taxus chinensis. It has been clinically proven to have good anti-tumor effects, especially for ovarian cancer, uterine cancer and breast cancer, which have a high incidence of cancer Wait for special effects. Paclitaxel is the most popular anticancer drug on the international market in recent years, and is considered to be one of the most effective anticancer drugs for humans in the next 20 years. Now the semi-synthetic method of paclitaxel is relatively mature, and it is considered to be an effective way to expand the source of paclitaxel besides artificial planting. The semi-synthetic method can maximize the utilization of plant resources, but it is not fundamentally differen...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/14A61K9/51A61K31/337A61K47/42A61K47/64A61P35/00
CPCA61K31/337A61K9/146A61K9/5169A61K47/643A61P35/00
Inventor 陈立江马徵薇王朝勃张金凤
Owner LIAONING UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap